Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized study of autologous bone marrow stem cell therapy and G-CSF after reperfused acute myocardial infarction
2004-005149-36Phase 4Active
- Sponsor
- Fundación General de la Universidad de Valladolid
- Start
- Mar 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of filgrastim in myocardial infarction (MI) (4 arms), sponsored by Fundación General de la Universidad de Valladolid. Primary endpoints: Left ventricular end-systolic volume, Left ventricular end-diastolic volume and 4 more. Started Mar 2012; status: active.
02
Drugs
filgrastim
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2004-005149-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005149-36.